Birchview Capital, LP - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$736,500
-9.7%
25,0000.0%0.63%
+2.6%
Q2 2023$815,500
+92570.5%
25,0000.0%0.61%
-11.3%
Q1 2023$880
-23.2%
25,0000.0%0.69%
-14.9%
Q4 2022$1,146
-99.9%
25,0000.0%0.81%
-5.0%
Q3 2022$1,211,000
+23.3%
25,0000.0%0.85%
+19.5%
Q2 2022$982,000
+6.7%
25,0000.0%0.71%
+7.9%
Q1 2022$920,000
-19.3%
25,0000.0%0.66%
-9.9%
Q4 2021$1,140,000
+27.5%
25,0000.0%0.74%
+20.9%
Q3 2021$894,000
+351.5%
25,000
+150.0%
0.61%
+415.3%
Q2 2021$198,000
+73.7%
10,0000.0%0.12%
+55.3%
Q3 2019$114,000
+0.9%
10,0000.0%0.08%
+10.1%
Q2 2019$113,000
+39.5%
10,0000.0%0.07%
+35.3%
Q1 2019$81,000
+28.6%
10,0000.0%0.05%
-15.0%
Q4 2018$63,000
-36.4%
10,0000.0%0.06%
-6.2%
Q3 2018$99,000
+19.3%
10,0000.0%0.06%
+14.3%
Q2 2018$83,000
+15.3%
10,0000.0%0.06%
+19.1%
Q1 2018$72,000
-12.2%
10,0000.0%0.05%
-2.1%
Q4 2017$82,000
-43.4%
10,0000.0%0.05%
-36.0%
Q3 2017$145,00010,0000.08%
Other shareholders
CYTOKINETICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders